RipE1 phosphorylation and NbUCH-mediated deubiquitination are independent mechanisms leading to RipE1 stability. by Wenjia Yu (9422059)

Kcnk5b requires CaMKK for growth and SHH/<i>shha</i> expression. by Xiaowen Jiang (8291814)

High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation by Mirzokhid Rakhmanov (580449)

The 27 proteins which were significantly deregulated in glia treated with AD plasma, but not deregulated in either control or MCI plasma treated glia (shown in Table 4) were analys... by Tharusha Jayasena (704509)

Effects of Cu (5 µM) pretreatment on Hcy-induced decrease in cell viability and LDH release. by Daoyin Dong (424519)

PSMα3N22Y has decreased chemotactic activity toward human neutrophils. by Gordon Y. C. Cheung (337723)

<i>HD</i> CAG and 3-NP Shared Decreased Expression of Glycolytic Genes by Jong-Min Lee (105338)

SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

“…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”

L-sel decreases the number of circulating lymphocytes. by Izabela Rozenberg (214521)

“…<p><i>ApoE</i>^{−<i>/</i>−}<i>L-sel</i>^{−<i>/</i>−} animals exhibit increased number of <b>A</b>) total blood lymphocytes (n = 5–8; ^*p<0.05), <b>B</b>) T-cytotoxic cells (CD8⁺; n = 6–7; ^**p<0.01, ^#p<0.05), <b>C</b>) B lymphocytes (CD19⁺; n = 5–7; ^*p<0.05, ^#p<0.05), <b>D</b>) total T-helper cells (CD4⁺; n = 6–7; ^#p<0.0), <b>E</b>) naive T-helper cells (CD4⁺CD44⁻; n = 5–7; ^*p<0.05; ^##p<0.0001) after 6 and 12 weeks of HCD, respectively. …”

Decrease of total symptom score during the study by R Lozano (33248)

C-terminal BNIP3 phosphorylation decreases the BNIP3-OPA1 interaction at the mitochondrial membrane. by Katherine E. Liu (759143)

Atorvastatin decreases proliferation of breast cancer cells more potently than rosuvastatin. by Colin H. Beckwitt (2037196)

S5 Raw image - by Zhi Xuan Low (19270163)

“…Furthermore, the inclusion complex exhibited reduced systemic toxicity, including reduced inflammation in vital organs as examined by hematoxylin and eosin (H&E) staining. This study also revealed a notable sequential reduction in serum levels of tumour markers, including carcinoembryonic antigen (CEA) and mouse Cytochrome P450 1A2 (CYP1A2), correlating with a significant decrease in tumour bulk volume upon treatment commencement. …”

Foskolin treatment to the fetal retina decreases corticogenesis. by Ciro Bonetti (147438)

“…<p>Intravitreal (I.V.) injection of foskolin at E15.5 and BrdU and analysis in E16.5 embryos. …”

Virus replication is decreased by treatment of HDAC inhibitors. by Angelika Danielsson (229695)

“…<p>LNCaP and PC-346C were transduced with Ad[i/PPT-E1A, E3] and Ad5 wt and BON cells were transduced with Ad[CgA-E1A] and Ad5 wt. …”

Transcriptomic analysis of the long-lived and short-lived Atg1 over-expressing flies reveals decreased lipid metabolism. by Ivana Bjedov (75652)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

Loss of <i>Bmp7</i> results in a decrease in cell proliferation in the cloacal regions, and defects in epithelial stratification. by Kun Xu (116877)

Decreased mRNA levels of inflammatory cytokines from <i>cpdm</i> BMDC. by Zhe Wang (41178)

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)